Loading clinical trials...
Loading clinical trials...
A Phase III, Multicentre, Double Blinded Study In Patients With Chronic Hepatitis C Who Are Non-Responders To Prior Peginterferon Alpha + Ribavirin Therapy Comparing Treatment With Thymosin Alpha 1 + Peginterferon Alpha-2a Plus Ribavirin With Peginterferon Alpha-2a + Ribavirin + Placebo
Conditions
Interventions
Thymosin alpha 1
Ribavirin
+2 more
Locations
9
France
Hôpital Necker
Paris, France
Universitätsklinikum Tübingen
Tübingen, Germany
University Hospital of Ioannina
Ioannina, Greece
Ospedale Casa Sollievo della Sofferenza
San Giovanni Rotondo, Foggia, Italy
Policlinico S.Orsola-Malpighi
Bologna, Italy
Ospedale Cardarelli
Naples, Italy
Start Date
December 1, 2004
Primary Completion Date
May 1, 2008
Completion Date
July 1, 2009
Last Updated
August 10, 2010
NCT00199719
NCT06922643
NCT03612973
NCT01866930
NCT05895448
NCT02219490
Lead Sponsor
sigma-tau i.f.r. S.p.A.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions